Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Men and women react differently to opioids, with hormones potentially influencing these differences.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Alternative treatments show promise for hair growth beyond traditional methods.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

DHT reduces a cell's ability to promote hair growth, while 3D culture without DHT improves it.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Antiandrogens are used to manage polycystic ovary syndrome by reducing androgen levels or controlling their effects, often combined with lifestyle changes and other treatments.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Researchers developed a method to detect hormone-blocking drugs in wastewater and found them in Beijing's sewage, suggesting they can survive sewage treatment.

Androgens prevent hair growth by changing Wnt signals in cells.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.